| HORIZON | TRADES | WIN RATE | INSIDER RETURN | SPY RETURN | MEAN EXCESS | MEDIAN EXCESS | T-STAT |
|---|---|---|---|---|---|---|---|
| 7d | 2 | +0.00% | +7.74% | +1.17% | +6.57% | +6.57% | — |
| 14d | 2 | +0.00% | +5.44% | +2.72% | +2.72% | +2.72% | — |
| 30d | 2 | +100.00% | -11.04% | -1.84% | -9.20% | -9.20% | — |
| 60d | 2 | +0.00% | +8.73% | +0.97% | +7.76% | +7.76% | — |
| 90d | 2 | +0.00% | +5.60% | +7.30% | -1.70% | -1.70% | — |
| 180d | 2 | +0.00% | +15.49% | +15.81% | -0.32% | -0.32% | — |
| 1y | 2 | +0.00% | +93.74% | +21.16% | +72.58% | +72.58% | — |
| 2y | 2(2 pending) | — | — | — | — | — | — |
| COMPANY | TYPE | SHARES | PRICE | VALUE | HELD AFTER | TRADE DATE | FILED | DETAILS |
|---|---|---|---|---|---|---|---|---|
| TRVI TREVI THERAPEUTICS, INC. | PURCHASEGRANT Stock grant | 160,000 | — | — | 160,000 | Feb 19, 2026 | Feb 20, 2026 ↗ | View → |
| TRVI TREVI THERAPEUTICS, INC. | PURCHASEGRANT Stock grant | 72,000 | — | — | 110,400 | May 31, 2025 | Jun 3, 2025 ↗ | View → |
| TRVI TREVI THERAPEUTICS, INC. | PURCHASE Chief Commercial Officer | 63,813 | $3.91 | $249.5K | 126,963 | Mar 10, 2025 | Mar 12, 2025 ↗ | View → |
| TRVI TREVI THERAPEUTICS, INC. | SALE Chief Commercial Officer | 17,500 | — | — | 0 | Mar 10, 2025 | Mar 12, 2025 ↗ | View → |
| TRVI TREVI THERAPEUTICS, INC. | SALE10b5-1 10b5-1 plan | 4,350 | $7.15 | $31.1K | 76,900 | Mar 10, 2025 | Mar 12, 2025 ↗ | View → |
| TRVI TREVI THERAPEUTICS, INC. | PURCHASE Chief Commercial Officer | 31,250 | $0.51 | $16.0K | 158,213 | Mar 10, 2025 | Mar 12, 2025 ↗ | View → |
| TRVI TREVI THERAPEUTICS, INC. | PURCHASEGRANT Stock grant | 38,400 | — | — | 38,400 | Mar 10, 2025 | Mar 12, 2025 ↗ | View → |
| TRVI TREVI THERAPEUTICS, INC. | PURCHASE Chief Commercial Officer | 17,500 | $3.21 | $56.2K | 63,150 | Mar 10, 2025 | Mar 12, 2025 ↗ | View → |
| TRVI TREVI THERAPEUTICS, INC. | SALE10b5-1 10b5-1 plan | 76,963 | $6.73 | $517.8K | 81,250 | Mar 10, 2025 | Mar 12, 2025 ↗ | View → |
| TRVI TREVI THERAPEUTICS, INC. | SALE Chief Commercial Officer | 31,250 | — | — | 18,750 | Mar 10, 2025 | Mar 12, 2025 ↗ | View → |
| TRVI TREVI THERAPEUTICS, INC. | SALE Chief Commercial Officer | 63,813 | — | — | 11,187 | Mar 10, 2025 | Mar 12, 2025 ↗ | View → |
| TRVI TREVI THERAPEUTICS, INC. | PURCHASEGRANT Stock grant | 225,500 | — | — | 225,500 | Feb 18, 2025 | Feb 20, 2025 ↗ | View → |
| TRVI TREVI THERAPEUTICS, INC. | PURCHASEGRANT Stock grant | 175,000 | — | — | 175,000 | Feb 15, 2024 | Feb 16, 2024 ↗ | View → |
| TRVI TREVI THERAPEUTICS, INC. | PURCHASE Chief Commercial Officer | 6,250 | $0.51 | $3.2K | 45,650 | Jun 20, 2023 | Jun 21, 2023 ↗ | View → |
| TRVI TREVI THERAPEUTICS, INC. | SALE Chief Commercial Officer | 6,250 | — | — | 50,000 | Jun 20, 2023 | Jun 21, 2023 ↗ | View → |
| TRVI TREVI THERAPEUTICS, INC. | PURCHASE Chief Commercial Officer | 18,750 | $0.51 | $9.6K | 39,400 | Mar 7, 2023 | Mar 7, 2023 ↗ | View → |
| TRVI TREVI THERAPEUTICS, INC. | SALE Chief Commercial Officer | 18,750 | — | — | 56,250 | Mar 7, 2023 | Mar 7, 2023 ↗ | View → |
| TRVI TREVI THERAPEUTICS, INC. | PURCHASEGRANT Stock grant | 100,000 | — | — | 100,000 | Feb 16, 2023 | Feb 16, 2023 ↗ | View → |